☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
AbCellera Collaborated with Rallybio to Develop and Commercialize Novel Antibody-Based Therapies for the Treatment of Rare Disease...
December 1, 2022
Insights+ Key Biosimilars Events of November 2022
December 1, 2022
IPA’s Subsidiary BioStrand Entered into a Research Collaboration and License Agreement with BriaCell to Discover and Develop Anti-...
December 1, 2022
Capstone’s Biosimilar Human Insulin Receives Marketing Authorization in Canada and EU
December 1, 2022
Liminatus Pharma Entered into a Definitive Business Combination Agreement with Iris to Advance the Cancer Treatment
December 1, 2022
Regeneron Reports the US FDA’s Acceptance of sBLA for Priority Review of Evkeeza (evinacumab) to Treat Homozygous Familial Hyperch...
December 1, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions